Facebook
Home
About
ENDECE Intellectual Property
Management Team
Scientific Advisory Board
Pipeline
ARDS
COVID-19
Multiple Sclerosis
Alzheimer’s Disease
Neuromyelitis Optica Spectrum Disorder
Niemann-Pick disease type C
Osmotic Demyelination Syndrome
News
Contact
Select Page
News
NEWS
NDC-1308: A Novel Therapeutic For Acute Respiratory Distress Syndrome (ARDS) Including COVID-19 Patients
NDC-1308 A Therapeutic for COVID-19 And Other Pulmonary Viruses
NDC-1308 A NOVEL THERAPEUTIC FOR COVID-19
NDC-1308 (MC1) Therapeutic for Seasonal Viral Influenza
Differences Between NDC-1308 (MC1) and Dexamethasone
